Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Post by Atomekon Mar 21, 2016 11:01am

302 Views

Post# 24683314

Short Positions for PLI

Symbol	Report Date	Volume	Change	Shares Issued	% Float
T : PLI	2016-03-15	3,511,250	261,091	582,039,643	0.60
T : PLI	2016-02-29	3,250,159	143,054	581,978,768	0.56
T : PLI	2016-02-15	3,107,105	412,609	581,978,768	0.53
T : PLI	2016-01-31	2,694,496	304,095	581,930,868	0.46